http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2006078056-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate | 2006-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2008-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2006078056-A1 |
titleOfInvention | Muscle satellite cell activator |
abstract | N- {1- [hydroxy (3-oxo-2-phenyl-1-cyclopropen-1-yl) methyl] -2-methylpropyl} -2-benzenesulfonylamino-4-methylpentanamide or an optical isomer thereof , Or a pharmaceutically acceptable salt thereof, or a muscular regeneration promoter containing an active ingredient thereof, or (2S) -N-{(1S) -1-[( S) -Hydroxy (3-oxo-2-phenyl-1-cyclopropen-1-yl) methyl] -2-methylpropyl} -2-benzenesulfonylamino-4-methylpentanamide, or a pharmaceutically acceptable salt thereof Or a hydrate or solvate thereof as an active ingredient. |
priorityDate | 2005-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 97.